February 09, 2026

Poststroke Spasticity, Seen Too Late

New guidance from the American Heart Association addresses delayed recognition of poststroke spasticity and outlines opportunities to improve timing of rehabilitation care.

Conexiant

February 05, 2026

Smell Screening With a Mobile Test

Researchers evaluated a rapid, self-administered mobile application–based test designed to screen for olfactory dysfunction in adult participants.

Conexiant

February 04, 2026

Plasma pTau217 Cutoffs for Clinical Use

Researchers assess how biological factors influence plasma biomarker interpretation for amyloid detection.

Conexiant

February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

February 02, 2026

Why So Many on BP Meds Still Miss Target

Most U.S. adults with hypertension missed blood pressure targets—including those on treatment—highlighting gaps in initiation and intensification of therapy, new JAMA data show.

Conexiant

January 30, 2026

Alzheimer Biomarkers Higher in Women

Researchers identify sex-specific differences in amyloid, tau, and brain structure during the seventh decade of life.

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

January 20, 2026

When Stroke Rehab Decisions Stall

Researchers examine how patient emotions, clinician communication, and rehabilitation system factors shape shared decision-making after stroke.

Conexiant

January 15, 2026

Lp(a) and Women's Long-Term Heart Risk

Findings support screening for elevated Lp(a) in healthy women.

Conexiant